Lab Website
Research Interests
Keywords: Inflammation, oxidative-stress, signal transduction, gene discovery, functional genomics and proteomics, gene regulation, molecular immunology, cancer research and neuro-inflammation.
Dr. Ting’s laboratory has broad interest in the application of cutting edge ideas and technology to the study of disease-relevant issues. Major directions include innate immunity, dendritic cell function, cell death, autophagy, signal transduction, gene discovery, functional genomics and proteomics, nanoparticles, gene regulation, neuro-inflammation and microglial cells. Clinical issues of interest include multiple sclerosis, cancer, autoimmune diseases, biologic therapy, infection and inflammation.
Immune gene transcription
Dr. Ting has studied the transcriptional master regulator of class II Major Histocompatibility (MHC) genes called CIITA (class II transactivator) for over a decade. CIITA is extremely important as patients with defects in the gene exhibit severe immunodeficiency.. CIITA promotes the recruitment of DNA-binding protein, transcription cofactors, and histone acetylases/methylases to the class II MHC promoters. More recently, her lab has found that another protein, NLRC5, which has a similar domain structure as CIITA can broadly regulate class I MHC in mice by modifying chromatin structure. Thus NLRC5 and CIITA are master regulators of class I and II MHC, which play central roles in adaptive immune activation.
NLRs: The NBD-LRR proteins regulate inflammatory cytokines, signaling and cell death
Based on the structure of CIITA, Dr. Ting found a large family of genes that encode similar structural motifs as CIITA. This was initially termed the CATERPILLER gene family, and now have been renamed NLRs. NLRs are important for immune defense against bacteria, viruses, fungi, parasites and damage-associated molecules. Mutations in NLRs are the primary genetic causes of several immunologic disorders. Beyond inflammation and infection, her group showed a strong effect of NLRs on cancer and metabolic diseases. RNA interference, gene ablation, genomics, yeast two-hybrid, biochemical and proteomics analyses are performed to understand the functions of these novel genes.
The Detrimental and Beneficial Roles of CNS Inflammation in Disease Progression and Resolution
Inflammation occurs in a number of neurologic diseases such as Alzheimer’s, Parkinson’s, Huntington’s and multiple sclerosis (MS). Using mice with mutations in inflammatory genes, Dr. Ting found that many of these genes, such as NLRs and cytokines, are not only crucial in disease progression (demyelination), but also in disease resolution (remyelination).
The role of immune plexins and semaphorins
Dr. Ting’s work in the plexin and semaphorin family originated because her lab found that CIITA also regulate plexin-A1 gene expression. Plexin-A1 is typically thought to be important for neuronal interaction and retraction. Her new finding presents a new framework to think about how immune cells attract and repulse each other. Her lab found that plexin-A1 and it ligand, Semaphorin 6D, are important for T cell activation. Additionally, they showed that Plexin-A4 and Semaphorin 3A interaction is important in sepsis, Plexin-D1 plays an important role in B cell activation, and Plexin-B2 influences cell movement. Thus this family has broad immune functions.
Core Techniques
Transcriptosome profiling, mass spectroscopy and proteome analysis, gene-ablation in mice and RNA interference, various models for cancer, autoimmune and inflammatory diseases.
Publications
Lab Members
Kathrine Barnett Ph.D.
June Brickey, Ph.D.
Weichun (Emily) Chou, Ph.D.
Haitao Guo, Ph.D.
Hao Guo, Ph.D.
Sirui (CiCi) Li, Ph.D.
Kaixin (Kathy) Liang – Graduate student
Adam Sandor, Ph.D.
Megan Schmidt, Ph.D.
Dingka Song, Ph.D.
Michael Thompson, MS
Elizabeth Guthrie, Ph.D.
Rebekah Watkins-Schulz, Graduate student- defends in March
Affiliation Links
Biological and Biomedical Sciences Program (BBSP)
Curriculum in Genetics and Molecular Biology (GMB)
Department of Microbiology-Immunology
Lineberger Comprehensive Cancer Center
Jenny Ting in UNC Genetics News

January 9, 2026
Ting Receives AAI Lifetime Achievement Award
Jenny Ting, PhD, William R. Kenan, Jr. Distinguished Professor in Genetics has been announced as the recipient of American Association of Immunologists’ Lifetime Achievement Award. Please join us in congratulating Dr. Ting on achieving this tremendous distinction!

December 2, 2025
Dr. Jenny Ting Named Highly Cited Researcher by Clarivate
29 Carolina faculty named ‘highly cited researchers’ including Dr. Jenny Ting, Distinguished Professor of Genetics, Microbiology and Immunology.

November 19, 2025
Jenny Ting Named 2026 Mark Brothers Award Recipient
The Indiana University School of Medicine has named Jenny Ting, PhD, William Rand Kenan, Jr. Distinguished Professor of Genetics, the recipient of the 2026 Mark Brothers Award. This honor recognizes an internationally renowned scientist of Asian descent for exceptional contributions to biomedical or clinical science. Dr. Ting, who also served as Co-Director of the Inflammatory …

November 5, 2025
Department of Genetics Publications for October 2025
Department of Genetics faculty, postdocs, students and collaborators published 40 papers in October 2025.

October 13, 2025
Department of Genetics Publications for September 2025
Department of Genetics faculty, postdocs, students and collaborators published 33 papers in September 2025.

January 20, 2025
Department of Genetics Publications for January 5th – 18th, 2025
Department of Genetics faculty, postdocs, students and collaborators published 18 papers during January 5th - 18th, 2025.

December 4, 2024
32 Carolina faculty including Katie Hoadley and Jenny Ting from UNC Genetics named ‘highly cited researchers’
Clarivate’s 2024 international list of trailblazers among peers includes scholars in the Department of Genetics and from across the University.

October 14, 2024
Department of Genetics Publications for September 15th – 28th, 2024
Department of Genetics faculty, postdocs, students and collaborators published 22 papers during September 15th - 28th, 2024.

July 26, 2024
Study Reveals “Cell Death Cascade” in Airway Cells Infected with SARS-CoV-2
Researchers in the lab of Jenny Ting, PhD, the William Kenan Distinguished Professor of Genetics and professor of microbiology and immunology, have made numerous findings about how cell death from SARS-CoV-2 infection may directly influence disease progression.

July 25, 2024
Genetics postdoctoral fellow Katherine Barnett awarded National Institute of Allergy and Infectious Diseases (NIAID) K99/R00 Pathway to Independence Award
Dr. Barnett is the recipient of a K99/R00 Pathway to Independence Award from the NIAID. Her project is entitled “Regulation of Pathologic Inflammasome Responses to SARS-CoV-2.” This award is for promising postdoctoral scientists to transition to independent, tenure-track faculty positions. This award will support the end of Dr. Barnett’s mentored postdoctoral research with Dr. Jenny …
